Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to FDA

Medical Professionals Reference (MPR)

FDA Greenlights Updated COVID-19 Vaccines; Bivalent Vaccines No Longer Authorized

Clinical Pharmacology September 29th 2023

MedTech Dive

FDA Finalizes Guidance on Cybersecurity for Medical Devices

All Specialties September 28th 2023

MDLinx

Many are Asking what is Going on with the Eye Drop Industry after Deaths and Injuries Linked to Products

Ophthalmology September 26th 2023

Medical Professionals Reference (MPR)

Miebo, a Prescription Eye Drop for Dry Eye Disease, Now Available

Optometry September 26th 2023

Oncology News Central (ONC)

FDA Updates Temozolomide Indications and Dosing

Oncology, Medical September 19th 2023

Practical Neurology

First Biosimilar to Treat Relapsing Multiple Sclerosis Approved by FDA

Neurology September 6th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form